Your session is about to expire
← Back to Search
Distress Tolerance Skills Training for Tourette Syndrome
N/A
Recruiting
Led By Joseph F. McGuire, Ph.D.
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
At least 18 years of age
Exhibit a tic frequency of at least one visible tic per minute
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 1 week after completion of distress tolerance skills training
Awards & highlights
Study Summary
This trial looks at whether teaching people with Tourette's how to better tolerate distress will help them better control their tics.
Who is the study for?
This trial is for adults over 18 with Tourette Syndrome who have moderate to severe tic symptoms, occurring at least once per minute. Participants must speak English and feel strong urges before tics (PUTS score >17) and struggle with distress (DTS score >30). It's not for those with heart issues, seizures, frostbite history, open sores on hands, or limb fractures.Check my eligibility
What is being tested?
The study tests whether teaching adults with Tourette's how to better handle distress can help them control their tics. The training aims to improve tolerance of uncomfortable feelings that lead to tics. Researchers will see if this makes behavior therapy more effective.See study design
What are the potential side effects?
Since the intervention involves skills training rather than medication, traditional side effects are not expected. However, participants may experience discomfort or emotional distress when learning to tolerate unpleasant sensations and emotions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
I have at least one visible tic every minute.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within 1 week after completion of distress tolerance skills training
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 1 week after completion of distress tolerance skills training
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Distress Tolerance Scale (DTS)
Secondary outcome measures
Yale Global Tic Severity Scale-Revised (YGTSS)
Trial Design
1Treatment groups
Experimental Treatment
Group I: Distress Tolerance Skills TrainingExperimental Treatment1 Intervention
Distress tolerance skills training is a multicomponent intervention drawn from third-wave cognitive-behavioral therapy (CBT) protocols.
Find a Location
Who is running the clinical trial?
Johns Hopkins UniversityLead Sponsor
2,263 Previous Clinical Trials
14,823,130 Total Patients Enrolled
7 Trials studying Tourette Syndrome
150 Patients Enrolled for Tourette Syndrome
Tourette Association of AmericaOTHER
11 Previous Clinical Trials
491 Total Patients Enrolled
11 Trials studying Tourette Syndrome
491 Patients Enrolled for Tourette Syndrome
Joseph F. McGuire, Ph.D.Principal InvestigatorJohns Hopkins University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a history of heart problems.Your DTS score is higher than 30 at Visit 2.I have a history of Reynaud's phenomenon.You have moderate or severe tics, shown by a score higher than 14 on the YGTSS Total Tic Score (or higher than 9 for adults with only motor or vocal tics).I am 18 years old or older.You have a broken bone in the limb that needs to be put in water.You cannot complete the rating questionnaires.I cannot attend the study visits.I have at least one visible tic every minute.You have had frostbite in the past.You have an open cut or sore on your hand.I have a history of fainting or seizures.Your score on the premonitory urge for tics scale (PUTS) is higher than 17 at Visit 2.
Research Study Groups:
This trial has the following groups:- Group 1: Distress Tolerance Skills Training
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many individuals are participating in this research project?
"Affirmative. Clinicaltrials.gov hosts information that confirms this trial is currently recruiting volunteers; it was first posted on June 2nd 2022 and has since been updated with new details, likewise on the same date. There are 35 patients to be recruited at a single location."
Answered by AI
Does this experiment have any open enrollment slots?
"Affirmative. Clinicaltrials.gov states that this clinical trial has resumed recruitment since its posting on June 2nd 2022, and is currently searching for 35 participants from a single site."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger